White label ELPA - ClinicalTrials.eu

Study of Recombinant Interferon-Gamma 1b Combined with Standard Treatment for Patients with Candidemia: Safety and Effectiveness Evaluation

Not recruiting

2 1 1 1
Investigated diseases:
- Systemic candida
Investigated drugs:
- Recombinant Human Interferon Gamma 1B
Study on [18F]-Fludarabine and Gadoteric Acid for Imaging in Patients with Newly Diagnosed Primary CNS Lymphoma

Not recruiting

1 1 1 1
Investigated diseases:
- Central nervous system lymphoma
Investigated drugs:
- 18F-Fludarabine
- Gadoteric Acid
Study on Nivolumab with Drug Combination for Patients with Intermediate Stage Liver Cancer

Not recruiting

4 1 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:
Study of NBTXR3 and Cetuximab with Radiotherapy for Elderly Patients with Advanced Head and Neck Cancer Not Eligible for Platinum Chemotherapy

Not recruiting

2 1 1 1
Investigated diseases:
- Head and neck cancer
Investigated drugs:
- Cetuximab
Study on Imaging-Guided Surgery for Prostate Cancer Patients Using [68Ga]PSMA-HBED-CC and [99mTc]PSMA I&S

Not recruiting

2 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- 2-[[5-[3-[[6-[[(5S)-5-Carboxy-5-[[(1S)-1,3-Dicarboxypropyl]Carbamoylamino]Pentyl]Amino]-6-Oxohexyl]Amino]-3-Oxopropyl]-2-Oxidophenyl]Methyl-[2-[[5-(2-Carboxyethyl)-2-Oxidophenyl]Methyl-(Carboxylatomethyl)Amino]Ethyl]Amino]Acetate:gallium-68(3+) Hydron
- [99MTC]PSMA I&S
Study on Niraparib and Dostarlimab for Patients with HPV-Negative Head and Neck Squamous Cell Carcinoma

Not recruiting

2 1 1 1
Investigated drugs:
- Niraparib
- Dostarlimab
Study of Durvalumab with Thoracic Radiotherapy and Chemotherapy for Patients with Extensive Stage Small Cell Lung Cancer After Initial Treatment

Not recruiting

2 1 1 1
Investigated diseases:
- Lung carcinoma cell type unspecified recurrent
Investigated drugs:
- Durvalumab
Study on Memantine Hydrochloride for Adolescents with Bipolar Disorder

Not recruiting

3 1 1
Investigated diseases:
- Bipolar disorder
Investigated drugs:
- Memantine Hydrochloride
Study on Mavorixafor for Treating WHIM Syndrome in Patients

Not recruiting

3 1
Investigated drugs:
- Mavorixafor
Study of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
- Ribociclib
- Letrozole

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies